Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Garrison

Showing results (131-140 of 165) with videos related to

Pageof 17
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 20, 2015
Adherence to evidence-based treatment guidelines for bipolar depression in an inpatient settingKathryn N Freeland, Brittany R Cogdill, Clint A Ross, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|July 1, 1994
Safety and effect of topical recombinant human interleukin-1beta in the management of pressure soresM C Robson, A Abdullah, B F Burns, et al.
Lab Animal|May 28, 2024
Temperature-dependent differences in mouse gut motility are mediated by stressAlvin Han, Courtney Hudson-Paz, Beatriz G Robinson, et al.
Cancer Chemotherapy and Pharmacology|January 27, 1998
Clinical effects and pharmacokinetics of the fusion protein PIXY321 in children receiving myelosuppressive chemotherapyW L Furman, J H Rodman, M E Tonda, et al.
Cancer|October 8, 1998
A Phase I study of granulocyte-macrophage-colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors: a report of the Children's Cancer GroupM S Cairo, M D Krailo, J A Weinthal, et al.
Proceedings of the Western Pharmacology Society|January 1, 1992
The cardiovascular and antiarrhythmic properties of a series of novel sparteine analogsM K Pugsley, M J Walker, G L Garrison, et al.
Cell Reports|March 31, 2026
A neuropeptide regulates cell non-autonomous protein homeostasisCarrie A Sheeler, Jacqueline Y Lo, Areebah Rahman, et al.
Journal of Chromatography|December 2, 1992
High-performance liquid chromatographic determination of BRB-I-28, a novel antiarrhythmic agent, in dog plasma and urineC L Chen, B A Lesseley, C R Clarke, et al.
Peerj|March 1, 2016
Spider phylogenomics: untangling the Spider Tree of LifeNicole L Garrison, Juanita Rodriguez, Ingi Agnarsson, et al.
Journal of Medicinal Chemistry|June 21, 1996
Novel 3,7-diheterabicyclo[3.3.1]nonanes that possess predominant class III antiarrhythmic activity in 1-4 day post infarction dog models: X-ray diffraction analysis of 3-[4-(1H-imidazol-1-yl)benzoyl]-7-isopropyl-3,7-diazabicyclo[3.3.1]nona ne dihydroperchlorateG L Garrison, K D Berlin, B J Scherlag, et al.
Pageof 17

Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 20, 2015
Adherence to evidence-based treatment guidelines for bipolar depression in an inpatient settingKathryn N Freeland, Brittany R Cogdill, Clint A Ross, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|July 1, 1994
Safety and effect of topical recombinant human interleukin-1beta in the management of pressure soresM C Robson, A Abdullah, B F Burns, et al.
Lab Animal|May 28, 2024
Temperature-dependent differences in mouse gut motility are mediated by stressAlvin Han, Courtney Hudson-Paz, Beatriz G Robinson, et al.
Cancer Chemotherapy and Pharmacology|January 27, 1998
Clinical effects and pharmacokinetics of the fusion protein PIXY321 in children receiving myelosuppressive chemotherapyW L Furman, J H Rodman, M E Tonda, et al.
Cancer|October 8, 1998
A Phase I study of granulocyte-macrophage-colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors: a report of the Children's Cancer GroupM S Cairo, M D Krailo, J A Weinthal, et al.
Proceedings of the Western Pharmacology Society|January 1, 1992
The cardiovascular and antiarrhythmic properties of a series of novel sparteine analogsM K Pugsley, M J Walker, G L Garrison, et al.
Cell Reports|March 31, 2026
A neuropeptide regulates cell non-autonomous protein homeostasisCarrie A Sheeler, Jacqueline Y Lo, Areebah Rahman, et al.
Journal of Chromatography|December 2, 1992
High-performance liquid chromatographic determination of BRB-I-28, a novel antiarrhythmic agent, in dog plasma and urineC L Chen, B A Lesseley, C R Clarke, et al.
Peerj|March 1, 2016
Spider phylogenomics: untangling the Spider Tree of LifeNicole L Garrison, Juanita Rodriguez, Ingi Agnarsson, et al.
Journal of Medicinal Chemistry|June 21, 1996
Novel 3,7-diheterabicyclo[3.3.1]nonanes that possess predominant class III antiarrhythmic activity in 1-4 day post infarction dog models: X-ray diffraction analysis of 3-[4-(1H-imidazol-1-yl)benzoyl]-7-isopropyl-3,7-diazabicyclo[3.3.1]nona ne dihydroperchlorateG L Garrison, K D Berlin, B J Scherlag, et al.
Pageof 17